You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human monoclonal antibody

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (VRC-HIVMAB0115-00-AB)

Recruiting
  • HIV
  • VRC-HIVMAB0115-00-AB
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Locally Advanced/Metastatic Solid Tumors Trial (PE0116&PE0105)

Not yet recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • (no location specified)
Mar 24, 2023

Rabies Virus Infection Trial in Kunming (Natural full human mAb CBB 1 injection, Rabies Human Immunoglobulin (HRIG), Natural

Not yet recruiting
  • Rabies Virus Infection
  • Natural full human monoclonal antibody CBB 1 injection
  • +3 more
  • Kunming, Yunnan, China
    The First Affiliated Hospital of Yunnan University of Traditiona
Apr 14, 2023

Lyme Disease Trial in Lincoln (2217LS, 0.9% Sodium Chloride (NaCl))

Completed
  • Lyme Disease
  • 2217LS
  • 0.9% Sodium Chloride (NaCl)
  • Lincoln, Nebraska
    Celerion Inc.
Sep 15, 2022

HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)

Completed
  • HIV Antibodies
  • VRC-HIVMAB091-00-AB
  • EDP
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 8, 2022

Malaria Trial in Baltimore (MAM01, Placebo)

Not yet recruiting
  • Malaria
  • MAM01
  • Placebo
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Advanced Solid Tumors Trial in Australia (HLX20)

Completed
  • Advanced Solid Tumors
  • Darlinghurst, New South Wales, Australia
  • +5 more
Jun 1, 2022

Colon Cancer, Pancreatic Cancer, Cholangiocarcinoma Trial run by the National Cancer Institute (NCI) (MVT-5873, pancreatectomy

Completed
  • Colon Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2022

COVID-19 Trial in Beijing (BRII-198, Placebo)

Completed
  • COVID-19
  • Beijing, Beijing, China
    Investigative Site
Mar 1, 2022

COVID-19 Trial in Beijing (BRII-196, Placebo)

Completed
  • COVID-19
  • Beijing, Beijing, China
    Investigative Site
Mar 1, 2022

HIV Trial in Boston (F105 Monoclonal Antibody (Human))

Completed
  • HIV Infections
  • F105 Monoclonal Antibody (Human)
  • Boston, Massachusetts
    Beth Israel Deaconess Med. Ctr., ACTG CRS
Oct 28, 2021

Pancreatic Carcinoma, Tumors That Express CA 19-9 Trial in Scottsdale, New York (MVT-1075, MVT-5873)

Suspended
  • Pancreatic Carcinoma
  • Tumors That Express CA 19-9
  • Scottsdale, Arizona
  • +1 more
Aug 23, 2022

Ventilator Associated Pneumonia, Staphylococcus Aureus Trial in Limoges (Suvratoxumab, Placebo)

Recruiting
  • Ventilator Associated Pneumonia
  • Staphylococcus Aureus
  • Suvratoxumab
  • Placebo
  • Limoges, France
    Research Site
Feb 1, 2023

Locally Advanced/Metastatic Solid Tumors Trial in Shanghai (PE0116)

Active, not recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • Shanghai, China
    复旦大学附属中山医院
Mar 23, 2023

Lymphoma Trial (BYON4228 + Rituximab)

Not yet recruiting
  • Lymphoma
  • BYON4228 + Rituximab
  • (no location specified)
Feb 20, 2023

Healthy Trial in Qingdao (VDJ001, Placebo)

Completed
  • Healthy
  • Qingdao, Shandong, China
    the Affliated Hospital of Qingdao University
Aug 30, 2023

Metastatic Carcinoma in the Liver, Resectable Mass, Stage IV Colorectal Cancer AJCC v7 Trial in Houston (biological, other,

Completed
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 30, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston

Recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Malaria Trial in Baltimore (VRC-MALMAB0100-00-AB, CHMI)

Completed
  • Malaria
  • Baltimore, Maryland
    University of Maryland Baltimore, Center for Vaccine Development
Nov 9, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Plaque Psoriasis Trial (BAT2306, EU-approved Cosentyx)

Recruiting
  • Plaque Psoriasis
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Jan 9, 2023

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

HIV Trial in Switzerland, United States (VRC07-523LS, Placebo)

Completed
Has Results
  • HIV Infections
  • VRC07-523LS
  • Placebo
  • Birmingham, Alabama
  • +6 more
Feb 21, 2022